High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ELVN
M
Enliven Therapeutics, Inc.
Kunkel Lori Anne
• Director
Equity Compensation
2025-12-17
$17,873x2
|
||||||
| ELVN |
Enliven Therapeutics, Inc.
|
Director
Equity Compensation
|
2025-12-17 | $17,873x2 | M | Form 4 |